TABLE II.

Sensitivity of Detection of Benign Pheochromocytoma/Paraganglioma

Reference	Patient-based sensitivity (lesion-based sensitivity in parenthesis)
	Number of patientsa	MIBG	SRS	FDG	FDA	FDOPA	CT	MRI
[110]	48	98%b
[111]	32	90.6%b					90%	93.3%
[66]	17	87.5%b	28.5%		87.5%		100%c	100%c
[112]	32		(25%)
[68]	12	83%d		58%
[57]	7 VHL	57%d			100%		100%	83%
[54]	20	(77%)b		(88%)	(77%)	(81%)	(100%)c	(100%)c
[69]	17	71%b				100%		100%
[71]	24	(52%)e				(85%)	(70%)c	(70%)c
[113]	22					100%	66%
[63]	25	(53%)b				97%

^aData for benign PGL only, some studies included both benign and malignant PGL.

^bI-123 MIBG.

^cStudies used either CT or MRI.

^dEither I-123 or I-131 MIBG.

^eI-131 MIBG.